Biliary Tract Carcinoma — Trials

Biliary Tract Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 238
Recruiting: 138
Ph III recruiting: 9
Growth YoY: +12.7%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (111)

clinicaltrialsPublishedShowing 51–61 of 61 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04634058	PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment	active not recruiting	Phase 2	40	Shanghai Zhongshan HospitalOTHER	1	Apr 16, 2025	clinicaltrials
NCT02170090	Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer(ACTICCA-1)	active not recruiting	Phase 3	789	Universitätsklinikum Hamburg-EppendorfOTHER